Specific allergen immunotherapy attenuates allergic airway inflammation in a rat model of Alstonia scholaris pollen induced airway allergy-Reference-Cited by-同舟云学术

Specific allergen immunotherapy attenuates allergic airway inflammation in a rat model of Alstonia scholaris pollen induced airway allergy

Published:2016-01 Issue: Volume:30 Page:111-120
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Datta Ankur,Moitra Saibal,Hazra Iman,Mondal Somnath,Das Prasanta Kumar,Singh Manoj Kumar,Chaudhuri Suhnrita,Bhattacharya Debanjan,Tripathi Santanu Kumar,Chaudhuri Swapna

Funder

Department of Science and Technology, Govt. of West Bengal, India

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference95 articles.

1. The Global Asthma Report, 2014;Network GA,2015

2. Allergic diseases and asthma: a major global health concern;Pawankar;Curr. Opin. Allergy Clin. Immunol.,2012

3. Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study;Dennis;BMC Pulm. Med.,2012

4. Sensitisation to aeroallergens among asthmatic and non-asthmatic adolescents living in a poor region in the Northeast of Brazil;Sarinho;Allergol. Immunopathol.,2009

5. Childhood asthma and indoor aeroallergens and endotoxin in Palestine: a case–control study;El-Sharif;J. Asthma,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of mesenchymal stem cell-derived exosomes for allergic airway inflammation;Cellular Immunology;2024-03

2. Immunology of Allergic Airway Diseases;Understanding Allergic Airway Diseases;2024

3. Sublingual prophylactic administration of OVA-loaded MSC-derived exosomes to prevent allergic sensitization;International Immunopharmacology;2023-07

4. Mesenchymal stem cells and allergic airway inflammation; a therapeutic approach to induce immunoregulatory responses;International Immunopharmacology;2023-07

5. Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants;International Immunopharmacology;2022-12